[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1091405261741404162.png) @JamesEKrause Biotech Jim

Biotech Jim posts on X about $mdgl, $abvx, $crvs, $951m the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1091405261741404162/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXX +127%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +44%

### Mentions: X [#](/creator/twitter::1091405261741404162/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:posts_active.svg)

- X Week XX +73%
- X Month XX +119%
- X Months XXX -XX%
- X Year XXX +169%

### Followers: XXXXXX [#](/creator/twitter::1091405261741404162/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:followers.svg)

- X Week XXXXXX +0.47%
- X Month XXXXXX +1.50%
- X Months XXXXXX +8%
- X Year XXXXXX +17%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1091405261741404162/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1091405261741404162/influence)
---

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [agencies](/list/agencies)  XXXX%

**Social topic influence**
[$mdgl](/topic/$mdgl) 3.45%, [$abvx](/topic/$abvx) 3.45%, [$crvs](/topic/$crvs) 3.45%, [$951m](/topic/$951m) 1.72%, [$arvn](/topic/$arvn) #1, [ogilvy](/topic/ogilvy) 1.72%, [$srpt](/topic/$srpt) 1.72%, [$regn](/topic/$regn) 1.72%, [$nktr](/topic/$nktr) 1.72%, [covalent](/topic/covalent) XXXX%

**Top accounts mentioned or mentioned by**
[@snicobio](/creator/undefined) [@investrclouseau](/creator/undefined) [@dreesenkl](/creator/undefined) [@bios_n_techs](/creator/undefined) [@sentivcapital](/creator/undefined) [@pjamess69](/creator/undefined) [@genomc50](/creator/undefined) [@lonondon](/creator/undefined) [@biomaven](/creator/undefined) [@balsageorge](/creator/undefined) [@ripster47](/creator/undefined) [@josephramelli](/creator/undefined) [@persimmonti](/creator/undefined) [@naturemedicine](/creator/undefined) [@xbiobserver](/creator/undefined) [@biohazard3737](/creator/undefined) [@andreagtc](/creator/undefined) [@caesarbiotech](/creator/undefined) [@iamtyred](/creator/undefined) [@robohogs](/creator/undefined)

**Top assets mentioned**
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Arvinas, Inc (ARVN)](/topic/$arvn) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm)
### Top Social Posts [#](/creator/twitter::1091405261741404162/posts)
---
Top posts by engagements in the last XX hours

"A look into the future Sino Biopharm buys Merck's PD-1xVEGF bispecific partner LaNova for up to $951M Lots of 👀👀👀 on this bispecific and the collaboration"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1945286039603454405) 2025-07-16 00:55:08 UTC 12.6K followers, 2449 engagements


"$ARVN Arvinas Inc reports initial in human data from its LRRK2 degrader program in Parkinson's Disease et al now this is a very good start"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1908123153290645744) 2025-04-04 11:43:05 UTC 12.6K followers, 9458 engagements


"Nice move by $MDGL on the patent extension news this morning. Methinks that the buyout will occur before the MAESTRO-NASH OUTCOMES trial in compensated cirrhosis is reported in 2027. Please do your own due diligence"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1945519554479763828) 2025-07-16 16:23:02 UTC 12.6K followers, 3011 engagements


"$MDGL Madrigal Pharmaceuticals Secures $XXX Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947741669496861047) 2025-07-22 19:32:55 UTC 12.6K followers, 1990 engagements


"@PJamess69 Perhaps this makes the potential acquirer(s) more anxious and now quicker at the draw to pay up Methinks also as to the buyout"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947788285864251533) 2025-07-22 22:38:10 UTC 12.6K followers, XXX engagements


"On intra-pancreatic beta cell communication by which glucagon modulates insulin release"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1946610074014683351) 2025-07-19 16:36:22 UTC 12.6K followers, 2040 engagements


""Only dead fish go with the flow." David Ogilvy"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947129015644430531) 2025-07-21 02:58:27 UTC 12.6K followers, 1781 engagements


"$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis Just had to sell my X day held position (in an IRA) for a 5+ bagger some sort of record for me. More than made up for that $SRPT blunder of mine"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947792711584481575) 2025-07-22 22:55:45 UTC 12.6K followers, 3927 engagements


"Own all three $ABVX $NKTR and $CRVS. That is my inflamm/onc strategy after some $REGN leaarnings. One key is the resistance mechanisms within patient subclasses. Another is being early on the science. Another is trying to figure out the role of Treg cells throughout the many valid disorders"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947825043163005111) 2025-07-23 01:04:13 UTC 12.6K followers, 1373 engagements


"@i_am_tyred I do thank you very much. I have a significant amount of $CRVS shares really like their covalent inhibitor approach and the drug MOA"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1945160672033054814) 2025-07-15 16:36:58 UTC 12.6K followers, XXX engagements


"Axsome Therapeutics had their "Frontiers in Brain Health R&D Day" ystdy and I am parking the slide show. I am largely lured to $AXSM due to their expanding CNS pipeline and the potential of AXS-05 in Alzheimer's Disease Agitation amongst other reasons. I point out slides 17-41 on ADA for a thorough review of the ADVANCE and ACCORD series of Ph3 trials. The black-boxed #Rexulti (brexpiprazole) from Otsuka and Lundbeck is the only FDA-approved to treat agitation associated with dementia due to Alzheimer's disease. We shall see how the new FDA treats Axsome with this filing but my view is that"  
![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1091405261741404162.png) [@JamesEKrause](/creator/x/JamesEKrause) on [X](/post/tweet/1947760109725356504) 2025-07-22 20:46:12 UTC 12.6K followers, 4558 engagements